Challenges in the Frontline Treatment of Patients With Chronic Lymphocytic Leukemia.
- Published in:
- Current Hematologic Malignancy Reports, 2010, v. 5, n. 1, p. 45, doi. 10.1007/s11899-009-0040-3
- By:
- Publication type:
- Article
Works matching IS 15588211 AND DT 2010 AND VI 5 AND IP 1
Results: 7
1
2
New Drugs for the Treatment of Myelofibrosis.
- Published in:
- Current Hematologic Malignancy Reports, 2010, v. 5, n. 1, p. 15, doi. 10.1007/s11899-009-0037-y
- By:
- Publication type:
- Article
3
New Agents in Chronic Lymphocytic Leukemia.
- Published in:
- Current Hematologic Malignancy Reports, 2010, v. 5, n. 1, p. 29, doi. 10.1007/s11899-009-0039-9
- By:
- Publication type:
- Article
4
JAK2 Mutation and Thrombosis in the Myeloproliferative Neoplasms.
- Published in:
- Current Hematologic Malignancy Reports, 2010, v. 5, n. 1, p. 22, doi. 10.1007/s11899-009-0038-x
- By:
- Publication type:
- Article
5
Lenalidomide in Myelodysplastic Syndromes: An Erythropoiesis-Stimulating Agent or More?
- Published in:
- Current Hematologic Malignancy Reports, 2010, v. 5, n. 1, p. 9, doi. 10.1007/s11899-009-0036-z
- By:
- Publication type:
- Article
6
Eradicating Minimal Residual Disease in Chronic Lymphocytic Leukemia: Should This Be the Goal of Treatment?
- Published in:
- Current Hematologic Malignancy Reports, 2010, v. 5, n. 1, p. 35, doi. 10.1007/s11899-009-0041-2
- By:
- Publication type:
- Article
7
High-Risk Myelodysplastic Syndromes: Chemotherapy, Transplantation, and Beyond.
- Published in:
- Current Hematologic Malignancy Reports, 2010, v. 5, n. 1, p. 1, doi. 10.1007/s11899-009-0035-0
- By:
- Publication type:
- Article